Stephane G. Carlier, MD, PhD

The Tryton Side-Branch Stent: Changing the Paradigm in Bifurcation Stenting

06/19/2008

Bifurcation lesions are common and have been reported to make up approximately 23% of currently treated lesions. In a series capturing ‘real world’ experience with drug-eluting stents, bifurcation lesions were associated with a greater than...

Bifurcation lesions are common...

06/19/2008

Cath Lab Digest

Feature

The Tryton Side-Branch Stent: Changing the Paradigm in Bifurcation Stenting

06/19/2008

Daniel Meyer ;

Stephane G. Carlier , MD, PhD;

Craig A. Thompson , MD, MMSc;

Bifurcation lesions are common...

06/19/2008

Cath Lab Digest

Original Contribution

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Alexandra J. Lansky , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

George D. Dangas , MD, PhD;

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

The Safety and Feasibility of Live-Stream Proctoring for CTO Procedures

08/07/2023

Paul Knaapen , MD, PhD;

Claudiu Ungureanu , MD;

Caroline Lepiece , MD;

Peter Kayaert , PhD, MD;

Gregory A. Sgueglia , PhD;

Gabriele Luigi Gasparini , MD;

Khaldoon Alaswad , MD;

Masahisa Yamane , MD, PhD;

Joseph "Jo" Dens , MD, PhD;

Kambis Mashayekhi , MD;

Stephane G. Carlier , MD, PhD;

Alexandre Avran , MD, PhD;

James C. Spratt , MD, FRCP, BSc, MBChB;

Overall, 9 patients underwent a percutaneous coronary intervention (PCI) targeting a chronic total occlusion (CTO) between June 2021 and January 2022 at a single Belgian center using the virtual proctoring approach. For this assessment, the...

Overall, 9 patients underwent a...

08/07/2023

Journal of Invasive Cardiology

Original Contribution

iFR/FFR/IVUS Discordance and Clinical Implications: Results From the Prospective Left Main Physiology Registry

05/01/2023

Luc Janssens , MD;

Johan Bennett , MD, PhD;

Panos Xaplanteris , MD;

Claudiu Ungureanu , MD;

Yoann Bataille , MD, PhD;

Peter Kayaert , PhD, MD;

Oscar Semeraro , MD;

Benny Drieghe , MD;

Joelle Kefer , MD, PhD;

Marc J. Claeys , MD, PhD;

Keir McCutcheon , MD, PhD;

Mathieu Coeman , MD;

Sofie Gevaert , MD, PhD;

Michel De Pauw , MD, PhD;

Steven Haine , MD, PhD;

Chadi Ghafari , MD;

Peter Gheeraert , MD, PhD;

Joseph "Jo" Dens , MD, PhD;

Bert Vandeloo , MD;

Stephane G. Carlier , MD, PhD;

Vincent Flore , MD, PhD;

Kurt Hermans , MD;

Georges Saad , MD;

This study aimed to assess discordance between results instantaneous wave-free ratio, fractional flow reserve, and intravascular ultrasound in intermediate left main coronary lesions.

This study aimed to assess...

05/01/2023

Journal of Invasive Cardiology

Frequency and Determinants of ‚ÄúBlack Holes‚Äù in Sirolimus-Eluting Stent Restenosis

08/01/2008

Stephane G. Carlier , MD, PhD;

Jeffrey W. Moses , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Masashi Kimura , MD, PhD;

Kenichi Fujii , MD;

Kaoru Tanaka , MD, PhD;

Joanna Lui , BA, MD;

Gary S. Mintz , MD;

Martin B. Leon , MD;

Koichi Sano , MD, PhD;

In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...

In-stent restenosis is the...

08/01/2008

Journal of Invasive Cardiology